Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro
I A Lyakhova
1
,
I S Bryukhovetsky
1, 2
,
I. V. Kudryavtsev
1
,
Yu S Khotimchenko
1, 2
,
M E Zhidkov
1
,
Publication type: Journal Article
Publication date: 2018-03-25
scimago Q3
wos Q4
SJR: 0.277
CiteScore: 1.5
Impact factor: 0.6
ISSN: 00074888, 15738221, 03659615, 24131008
PubMed ID:
29577186
General Biochemistry, Genetics and Molecular Biology
General Medicine
Abstract
Antitumor efficiency of fascaplysin synthetic derivatives (7-phenylfascaplysin, 3-chlorofascaplysin, 3-bromofascaplysin, and 10-bromofascaplysin) was compared out in vitro on C6 glioma cells. The cytotoxic efficiency of all tested compounds was higher than that of unsubstituted fascaplysin; 3-bromofascaplysin and 7-phenylfascaplysin exhibited the best capacity to kill glioma C6 cells. Apoptosis was the main mechanism of glioma cell death. The cytotoxic activity of these compounds increased with prolongation of exposure to the substance and increase of its concentration. Fascaplysin derivatives modified all phases of glioma cell vital cycle. The count of viable tumor cell in G0 phase remained minimum by the end of experiment under the effects of 3-bromofascaplysin and 7-phenylfascaplysin.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
8
|
|
|
Marine Drugs
8 publications, 50%
|
|
|
International Review of Neurobiology
2 publications, 12.5%
|
|
|
Biomedicines
1 publication, 6.25%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 6.25%
|
|
|
ChemistrySelect
1 publication, 6.25%
|
|
|
Studies in Natural Products Chemistry
1 publication, 6.25%
|
|
|
Molecules
1 publication, 6.25%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 6.25%
|
|
|
1
2
3
4
5
6
7
8
|
Publishers
|
2
4
6
8
10
|
|
|
MDPI
10 publications, 62.5%
|
|
|
Elsevier
5 publications, 31.25%
|
|
|
Wiley
1 publication, 6.25%
|
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
16
Total citations:
16
Citations from 2024:
3
(18.75%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Lyakhova I. A. et al. Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro // Bulletin of Experimental Biology and Medicine. 2018. Vol. 164. No. 5. pp. 666-672.
GOST all authors (up to 50)
Copy
Lyakhova I. A., Bryukhovetsky I. S., Kudryavtsev I. V., Khotimchenko Yu. S., Zhidkov M. E., Kantemirov A. V. Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro // Bulletin of Experimental Biology and Medicine. 2018. Vol. 164. No. 5. pp. 666-672.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1007/s10517-018-4055-4
UR - https://doi.org/10.1007/s10517-018-4055-4
TI - Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro
T2 - Bulletin of Experimental Biology and Medicine
AU - Lyakhova, I A
AU - Bryukhovetsky, I S
AU - Kudryavtsev, I. V.
AU - Khotimchenko, Yu S
AU - Zhidkov, M E
AU - Kantemirov, A V
PY - 2018
DA - 2018/03/25
PB - Springer Nature
SP - 666-672
IS - 5
VL - 164
PMID - 29577186
SN - 0007-4888
SN - 1573-8221
SN - 0365-9615
SN - 2413-1008
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2018_Lyakhova,
author = {I A Lyakhova and I S Bryukhovetsky and I. V. Kudryavtsev and Yu S Khotimchenko and M E Zhidkov and A V Kantemirov},
title = {Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro},
journal = {Bulletin of Experimental Biology and Medicine},
year = {2018},
volume = {164},
publisher = {Springer Nature},
month = {mar},
url = {https://doi.org/10.1007/s10517-018-4055-4},
number = {5},
pages = {666--672},
doi = {10.1007/s10517-018-4055-4}
}
Cite this
MLA
Copy
Lyakhova, I. A., et al. “Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro.” Bulletin of Experimental Biology and Medicine, vol. 164, no. 5, Mar. 2018, pp. 666-672. https://doi.org/10.1007/s10517-018-4055-4.